Note

- Stock-based compensation

The Company’s

2017

Omnibus Stock Incentive Plan dated

June 13, 2017,

as amended, which the Company's stockholders approved in

June 2017 (

"2017

Plan"), is the only incentive stock plan under which new equity incentive awards

may

be granted.

The Company has prior incentive plans under which previously granted awards remain outstanding, but under which

new awards

may

be granted. At

October 31, 2019

the Company had reserved a total of

694,989

shares for grants and issuances under these incentive stock plans, which includes a reserve for issuances pursuant to unvested or unexercised prior awards, and shares for new grants or issuances pursuant to the

2017

Plan.

While the

2017

Plan provides for the grant of deferred shares, non-qualified stock options, incentive stock options, restricted shares, restricted stock units, and performance-based restricted stock units intended to qualify under section

422

of the Internal Revenue Code, to date the Company has issued only restricted shares and restricted stock units under the

2017

Plan and currently intends to continue this practice. The

2017

Plan authorizes awards to officers, employees, consultants and independent directors.

The Company has stock-based compensation awards that can be granted to eligible employees, officers or independent directors. The following is the stock-based compensation expense:

	Three Months Ended October 31,				Nine Months Ended October 31,
	2019		2018		2019		2018
Stock-based compensation expense	$	2	$	5	$	10	$	28
Restricted stock-based compensation expense		224		283		776		971
Total stock-based compensation expense	$	226	$	288	$	786	$	999

Stock Options

The Company did

not

grant any stock options during the

three

nine

months ended

October 31, 2019

. The following tables summarizes the Company's stock option activity:

Option activity	No. of Shares Underlying Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding (unvested) at January 31, 2019		218		$	8.60		3.8	$	257
Exercised		(47	)		6.87				100
Expired or forfeited		(26	)		7.07
Outstanding at October 31, 2019		145			9.03		3.4		167

Exercisable at October 31, 2019		143		$	9.07		3.3	$	163

The Company received approximately

$0.3

million during the

nine

months ended

October 31, 2019

for stock options exercised.

Unvested option activity	No. of Shares Underlying Options			Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Outstanding (unvested) at January 31, 2019		11		$	7.00	$	19
Vested		(7	)
Expired or forfeited		(2	)		7.07
Outstanding at October 31, 2019		2		$	7.33	$	5

As of

October 31, 2019

, there was less than $

0.1

million of total unrecognized compensation expense related to unvested stock options. The expense is expected to be recognized over a weighted average period of

0.6

years.

Restricted stock

The following table summarizes the Company's restricted stock activity for the

first

nine

months of fiscal

2019:

Restricted stock activity	Restricted Shares			Weighted Average Grant Price Per Share		Aggregate Intrinsic Value
Outstanding (unvested) at January 31, 2019		283		$	8.74	$	2,476
Granted		152			9.09
Vested and issued		(52	)		8.86
Forfeited or retired for taxes		(24	)		8.68
Outstanding (unvested) at October 31, 2019		359		$	8.98	$	3,229

s of

October 31, 2019

, there was

$1.7

million of unrecognized compensation expense related to unvested restricted stock granted under the plans. That cost is expected to be recognized over a weighted average period of

2.3

years.